Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBI Trial
PACTR202107707978619Phase 3Completed
- Sponsor
- Zvitambo Institute for Maternal and Child Health Research
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of trimethoprim + sulfamethoxazole in human immunodeficiency virus infection (HIV) and pregnancy (2 arms), sponsored by Zvitambo Institute for Maternal and Child Health Research. Primary endpoint: Infant birth weight. Started Sep 2021; status: completed.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
human immunodeficiency virus infection (HIV)pregnancy
Beyond the preview
Go deeper on PACTR202107707978619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202107707978619.